Back

Distinct cellular and molecular trajectories leading to subclinical diastolic dysfunction and the progression to HFpEF

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Basic and Translational Late-Breaking Science Diastolic Ventricular Dysfunction ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Enrique Lara-Pezzi

National Centre for Cardiovascular Research (CNIC), Madrid (Spain)

7 More presentations in this session

Presentation thumbnail
Gut Microbiota and Associated Metabolites Play a Key Role in the Pathogenesis of the Obesity Phenotype of Heart Failure With Preserved Ejection Fraction
Associate Professor R. Asleh (Jerusalem, IL)
Slides Video
Presentation thumbnail
Different cardiovascular outcomes of vascular ageing proteomic phenogroups in normotensive and hypertensive individuals: results from the UK Biobank.
Professor T. Guzik (Edinburgh, GB)
Slides Video
Presentation thumbnail
Polygenic traits and cardiac remodelling contribute to a markedly increased risk of atrial fibrillation in former elite endurance athletes
Professor A. La Gerche (Melbourne, AU)
Slides Video
Presentation thumbnail
Echocardiographic screening for cardiac amyloidosis using artificial intelligence: A multi-site study for algorithm training and external validation.
Professor P. Pellikka (Rochester, US)
Slides Video
Presentation thumbnail
An isocaloric high fat diet enriched with saturated compared to polyunsaturated fat has a more detrimental effect on clinical cardiometabolic risk factors in healthy humans
Mr N. Srnic (Oxford, GB)
Slides Video

Access the full session

Session thumbnail
Basic and Translational Late-Breaking Science
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
LV diastolic function: how to deal with challenges
thumbnail
Congress Presentation
Links between abnormal exercise parameters and diastolic dysfunction in heart failure with reduced ejection fraction
thumbnail
Congress Presentation
Diastolic dysfunction and survival in patients with preserved or mildly reduced left ventricular ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources